ABSTRACT
In a longitudinal study on 181 naïve patients who responded to therapy (mean follow-up 4 years), high baseline human immunodeficiency virus (HIV)-RNA values correlated with high levels of cellular HIV-DNA at all time points (p < 0.0001, p 0.045, p 0.0055, and p 0.0025, respectively) and negatively correlated with undetectable residual viremia (URV; <2.5 copies/mL) at T1, T2, and T3 (p 0.026, p 0.0149, and p 0.0002, respectively). Baseline high HIV-DNA levels predicted the persistence of high values (p 0.0001) and negatively correlated with URV (p 0.0254, p 0.0481, and p 0.0085). These results suggest that baseline viral load, cellular HIV-DNA, and URV were strongly correlated over long-term follow-up of antiretroviral therapy responders.
Subject(s)
Antiretroviral Therapy, Highly Active , HIV Infections/drug therapy , HIV Infections/virology , HIV-1/genetics , Leukocytes, Mononuclear/virology , Viral Load , Viremia , Adult , CD4 Lymphocyte Count , DNA, Viral , Female , Follow-Up Studies , Genotype , HIV Infections/epidemiology , Humans , Longitudinal Studies , Male , Middle Aged , Treatment OutcomeABSTRACT
Chronic viral hepatitis is a common co-morbidity in Italian HIV-infected patients. It represents an important emergent associated risk of mortality in patients with HIV infection whose survival has increasingly improved by highly active antiretroviral therapy. In such patients further infectious predisposing factors, related to hepatic failure and esophageal haemorrhage, worsen the immunodeficiency due to HIV infection. Bacterial peritonitis has been reported in 3% of patients after esophageal endoscopic injection sclerotherapy emergency and in 0,5% of elective procedure. Combined antibiotic prophylaxis with aminopenicillins beta-lactamase inhibitor and fluoroquinolone should be regularly given to AIDS patients with decompensated liver cirrhosis who have esophageal variceal bleeding. A case of a pneumococcal bacterial peritonitis following emergency esophageal endoscopic sclerotherapy for variceal bleeding in patient with AIDS and liver cirrhosis with ascites is reported.
Subject(s)
AIDS-Related Opportunistic Infections/etiology , Esophageal and Gastric Varices/therapy , Gastrointestinal Hemorrhage/therapy , Peritonitis/etiology , Pneumococcal Infections/etiology , Sclerotherapy , AIDS-Related Opportunistic Infections/microbiology , Adult , Antibiotic Prophylaxis , Ascitic Fluid/microbiology , Bacterial Translocation , Emergencies , Esophageal and Gastric Varices/etiology , Female , Gastrointestinal Hemorrhage/etiology , Hepatitis C, Chronic/complications , Humans , Liver Cirrhosis/complications , Streptococcus pneumoniae/isolation & purification , Streptococcus pneumoniae/physiology , Substance Abuse, Intravenous/complicationsABSTRACT
A 69-year-old male heart transplant recipient, being treated with Cell Cept, FK 506 and methylprednisolone had multiple deep brown skin nodules and nodes, on the upper right arm. Skin biopsy and culture detected a strain of Curvularia lunata. The infection disseminated to the whole skin surface, oral mucosa, upper third of the oesophagus and to the lungs. Therapy with antibiotics and antifungal drugs was ineffective. The patient died of sepsis. We did not find any other case of systemic dissemination from a skin infection due to C. lunata among heart transplant recipients. We feel that heart transplant recipients need adequate education to prevent situations that would put them at risk for infection and to seek medical advice immediately for an early diagnosis and an effective therapy.
Subject(s)
Dermatomycoses/diagnosis , Fungemia/diagnosis , Heart Transplantation/adverse effects , Mitosporic Fungi , Opportunistic Infections/diagnosis , Aged , Anti-Bacterial Agents , Antifungal Agents/therapeutic use , Dermatomycoses/drug therapy , Disease Progression , Drug Therapy, Combination/therapeutic use , Fatal Outcome , Fungemia/drug therapy , Heart Transplantation/methods , Humans , Immunocompromised Host , Male , Opportunistic Infections/drug therapyABSTRACT
In a retrospective study, 42 (7.7%) of 545 patients with AIDS from a single area of Italy had non-Hodgkin's lymphoma (28 systemic and 14 primary central nervous system lymphomas). The improved outcome and survival of treated patients outlines the clinical benefit of antineoplastic treatment in selected cases.